COc1cccc(-n2c(=O)c3c(C)c(C(=O)N(C)C)sc3n(Cc3cccc(C)c3)c2=O)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?